Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
Skycorp Solar Group has just lived through one of the more dramatic short-squeeze cycles seen in a micro-cap name this year — and the aftermath is almost as striking as the peak. The story starts with a catalyst. On…
RENX enters its post-earnings stretch in an uncomfortable spot: a Q1 earnings miss just confirmed, short interest still elevated at nearly 8% of the free float, and borrow costs that remain among the most punishing on…
CRVO heads into Tuesday's Q1 earnings call with the stock down 13% on the month, a just-released EPS miss already on the tape, and short sellers quietly adding exposure for the past six weeks. The catalyst for Friday's…
INTJ heads into the back half of May with short sellers at their most subdued in months — and the price action appears to be the reason. The most striking dynamic is the steady retreat of short positions over the past…
LQR House arrives at its May 21 earnings date on a sharp week — up 18% in five sessions to $1.03 — but the fundamentals underneath that move are complicated. Q1 results released Thursday after the close showed revenue…
Advanced Biomed Inc. heads into its May 21 earnings event with a striking story: shorts that spent three weeks piling in have unwound almost entirely, while borrow costs remain among the most extreme in the market. The…
HUBC has cratered 98% in a single month, leaving short sellers sitting on extraordinary exposure — and raising questions about what, if anything, is left to short against. The price collapse is the defining fact here.…
Cardio Diagnostics Holdings heads into its May 20 earnings release with the stock down 15% on the week, shorts unwinding fast, and borrow costs running at nearly triple digits — a confusing mix of signals for a stock…
Wetour Robotics Limited heads into the weekend having gained 17% on the week, yet the number of shares sold short multiplied more than sixfold in the same period — a divergence that makes the stock one of the more…
Seadrill enters the back half of May with a head of steam. The stock climbed 9% this week to $52.70, its strongest weekly gain since the start of the year, and the catalyst is clear: a high-conviction analyst upgrade…
SHPH heads into its May 21 earnings call as a company mid-transformation — abandoning its pharmaceutical identity for Dogecoin mining, while short sellers who crowded the trade are rushing for the exits. The most…
Li Bang International Corporation Inc. heads into the weekend defined by a single extraordinary data point — short interest plunged 82% in one week, one of the sharpest unwinds in the stock's recent history. The short…
SUNation Energy Inc. heads into next week's earnings with short sellers in full retreat — but the borrow market tells a more complicated story. Short interest has collapsed by 20% over the past week, falling from…
U-BX Technology has become one of the more dramatic setups in US small-cap this week — a stock down 64% in five sessions while short sellers have simultaneously built their largest position on record. Short interest is…
Maris-Tech has spent the past six weeks on an unusual journey — from a heavily-shorted, triple-digit borrow cost situation in early April to a much quieter lending market today. That unwinding is the story worth…
Onfolio Holdings heads into its Q1 2026 earnings call on May 18 with a brutal week behind it — a 23% price decline — and a paradox at its core: short sellers have been abandoning the trade even as the fundamental news…
Allarity Therapeutics enters its Q1 2026 earnings call on May 22 having shed 13% over the past week, and the tension is straightforward: a clinical-stage biotech with no revenue, a binary pipeline, and a print arriving…
Knightscope enters its May 18 investor update carrying one of the most congested short books in its history — 24% of the float is sold short, availability is near rock bottom, and the stock has shed 13% in a…
CERO, the micro-cap biotech trading on OTC markets at $0.027, heads into the back half of May with a dramatic-looking short interest jump that almost entirely dissolves under closer inspection. The headline number is…
P3 Health Partners just delivered one of the most violent single-day moves in the small-cap healthcare space this year. The stock closed May 15 at $11.29 — up 218% on the week and 368% over the past month — after a Q1…
